Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes
Background. Type 2 diabetes (T2D) as a worldwide chronic disease combined with the COVID-19 pandemic prompts the need for improving the management of hospitalized COVID-19 patients with preexisting T2D to reduce complications and the risk of death. This study aimed to identify clinical factors assoc...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2022/9322332 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565216243613696 |
|---|---|
| author | Yuanyuan Fu Ling Hu Hong-Wei Ren Yi Zuo Shaoqiu Chen Qiu-Shi Zhang Chen Shao Yao Ma Lin Wu Jun-Jie Hao Chuan-Zhen Wang Zhanwei Wang Richard Yanagihara Youping Deng |
| author_facet | Yuanyuan Fu Ling Hu Hong-Wei Ren Yi Zuo Shaoqiu Chen Qiu-Shi Zhang Chen Shao Yao Ma Lin Wu Jun-Jie Hao Chuan-Zhen Wang Zhanwei Wang Richard Yanagihara Youping Deng |
| author_sort | Yuanyuan Fu |
| collection | DOAJ |
| description | Background. Type 2 diabetes (T2D) as a worldwide chronic disease combined with the COVID-19 pandemic prompts the need for improving the management of hospitalized COVID-19 patients with preexisting T2D to reduce complications and the risk of death. This study aimed to identify clinical factors associated with COVID-19 outcomes specifically targeted at T2D patients and build an individualized risk prediction nomogram for risk stratification and early clinical intervention to reduce mortality. Methods. In this retrospective study, the clinical characteristics of 382 confirmed COVID-19 patients, consisting of 108 with and 274 without preexisting T2D, from January 8 to March 7, 2020, in Tianyou Hospital in Wuhan, China, were collected and analyzed. Univariate and multivariate Cox regression models were performed to identify specific clinical factors associated with mortality of COVID-19 patients with T2D. An individualized risk prediction nomogram was developed and evaluated by discrimination and calibration. Results. Nearly 15% (16/108) of hospitalized COVID-19 patients with T2D died. Twelve risk factors predictive of mortality were identified. Older age (HR = 1.076, 95% CI = 1.014–1.143, p=0.016), elevated glucose level (HR = 1.153, 95% CI = 1.038–1.28, p=0.0079), increased serum amyloid A (SAA) (HR = 1.007, 95% CI = 1.001–1.014, p=0.022), diabetes treatment with only oral diabetes medication (HR = 0.152, 95%CI = 0.032–0.73, p=0.0036), and oral medication plus insulin (HR = 0.095, 95%CI = 0.019–0.462, p=0.019) were independent prognostic factors. A nomogram based on these prognostic factors was built for early prediction of 7-day, 14-day, and 21-day survival of diabetes patients. High concordance index (C-index) was achieved, and the calibration curves showed the model had good prediction ability within three weeks of COVID-19 onset. Conclusions. By incorporating specific prognostic factors, this study provided a user-friendly graphical risk prediction tool for clinicians to quickly identify high-risk T2D patients hospitalized for COVID-19. |
| format | Article |
| id | doaj-art-1905ef5f8c164eedbc156b5aa0e76c05 |
| institution | Kabale University |
| issn | 1687-8345 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-1905ef5f8c164eedbc156b5aa0e76c052025-02-03T01:08:57ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/9322332Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 DiabetesYuanyuan Fu0Ling Hu1Hong-Wei Ren2Yi Zuo3Shaoqiu Chen4Qiu-Shi Zhang5Chen Shao6Yao Ma7Lin Wu8Jun-Jie Hao9Chuan-Zhen Wang10Zhanwei Wang11Richard Yanagihara12Youping Deng13Department of Quantitative Health SciencesTianyou HospitalTianyou HospitalDepartment of Quantitative Health SciencesDepartment of Quantitative Health SciencesTianyou HospitalTianyou HospitalTianyou HospitalTianyou HospitalTianyou HospitalTianyou HospitalCancer Epidemiology ProgramDepartment of PediatricsDepartment of Quantitative Health SciencesBackground. Type 2 diabetes (T2D) as a worldwide chronic disease combined with the COVID-19 pandemic prompts the need for improving the management of hospitalized COVID-19 patients with preexisting T2D to reduce complications and the risk of death. This study aimed to identify clinical factors associated with COVID-19 outcomes specifically targeted at T2D patients and build an individualized risk prediction nomogram for risk stratification and early clinical intervention to reduce mortality. Methods. In this retrospective study, the clinical characteristics of 382 confirmed COVID-19 patients, consisting of 108 with and 274 without preexisting T2D, from January 8 to March 7, 2020, in Tianyou Hospital in Wuhan, China, were collected and analyzed. Univariate and multivariate Cox regression models were performed to identify specific clinical factors associated with mortality of COVID-19 patients with T2D. An individualized risk prediction nomogram was developed and evaluated by discrimination and calibration. Results. Nearly 15% (16/108) of hospitalized COVID-19 patients with T2D died. Twelve risk factors predictive of mortality were identified. Older age (HR = 1.076, 95% CI = 1.014–1.143, p=0.016), elevated glucose level (HR = 1.153, 95% CI = 1.038–1.28, p=0.0079), increased serum amyloid A (SAA) (HR = 1.007, 95% CI = 1.001–1.014, p=0.022), diabetes treatment with only oral diabetes medication (HR = 0.152, 95%CI = 0.032–0.73, p=0.0036), and oral medication plus insulin (HR = 0.095, 95%CI = 0.019–0.462, p=0.019) were independent prognostic factors. A nomogram based on these prognostic factors was built for early prediction of 7-day, 14-day, and 21-day survival of diabetes patients. High concordance index (C-index) was achieved, and the calibration curves showed the model had good prediction ability within three weeks of COVID-19 onset. Conclusions. By incorporating specific prognostic factors, this study provided a user-friendly graphical risk prediction tool for clinicians to quickly identify high-risk T2D patients hospitalized for COVID-19.http://dx.doi.org/10.1155/2022/9322332 |
| spellingShingle | Yuanyuan Fu Ling Hu Hong-Wei Ren Yi Zuo Shaoqiu Chen Qiu-Shi Zhang Chen Shao Yao Ma Lin Wu Jun-Jie Hao Chuan-Zhen Wang Zhanwei Wang Richard Yanagihara Youping Deng Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes International Journal of Endocrinology |
| title | Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes |
| title_full | Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes |
| title_fullStr | Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes |
| title_full_unstemmed | Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes |
| title_short | Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes |
| title_sort | prognostic factors for covid 19 hospitalized patients with preexisting type 2 diabetes |
| url | http://dx.doi.org/10.1155/2022/9322332 |
| work_keys_str_mv | AT yuanyuanfu prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT linghu prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT hongweiren prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT yizuo prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT shaoqiuchen prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT qiushizhang prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT chenshao prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT yaoma prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT linwu prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT junjiehao prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT chuanzhenwang prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT zhanweiwang prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT richardyanagihara prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes AT youpingdeng prognosticfactorsforcovid19hospitalizedpatientswithpreexistingtype2diabetes |